Cancer United

From SourceWatch
Jump to navigation Jump to search
Front groups badge.png

This article is part of the Center for Media & Democracy's spotlight on front groups and corporate spin.

Cancer United is a pharmaceutical industry front group established by the Weber Shandwick public relations firm and funded entirely by Roche.

In August 2006, Guardian journalist Sarah Boseley wrote ahead of the group's launch that it "is being presented as a pioneering effort by a coalition of doctors, nurses and patients to push for equal access to cancer care across the EU. However, the campaign is being entirely funded by Roche, the maker of Herceptin and Avastin. A senior company executive sits on the board. The company's PR firm, Weber Shandwick has been heavily promoting the group to clinicians and journalists. The principal study on which the group is based was also funded by Roche Laboratories and has been hotly contested. [1]

Contact Details


Articles & sources

SourceWatch Resources


  1. Sarah Boseley, "Concern over cancer group's link to drug firm", Guardian (UK), October 18, 2006.

External articles